What are Vir Biotechnology, Inc.'s profit margins?

Vir Biotechnology, Inc. (VIR) runs a 96.1% gross margin and a -720.8% operating margin, with a -676.0% net margin.

Where do Vir Biotechnology, Inc.'s ratios come from?

Every ratio is computed from Vir Biotechnology, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Vir Biotechnology, Inc. VIR Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Operating margin	-720.8%-21.6pp	-699.2%+2,554pp	-3,253.6%-61.9pp	-3,191.7%-92.0pp	-3,099.7%-2,308pp
Net margin	-676%-37.1pp	-638.9%+2,325pp	-2,963.5%-67.6pp	-2,895.9%-127pp	-2,769%-2,066pp
Returns
Return on equity	-47.7%-2.0pp	-45.7%+3.3pp	-49.1%-2.8pp	-46.2%-1.6pp	-44.6%-6.5pp
Return on invested capital	-67.6%-5.8pp	-61.8%-1.0pp	-60.7%+0.7pp	-61.4%-4.2pp	-57.2%-7.9pp
Efficiency
Asset turnover	0.1×0.0×	0.1×0.0×	0×0.0×	0×0.0×	0×0.0×
Liquidity
Current ratio	7.1×+1.6×	5.5×-1.7×	7.3×+0.2×	7×+0.2×	6.8×-1.9×
Leverage
Debt-to-equity	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Per Share
Book value per share	$5.52-0.2%	$5.52-3.6%	$5.73-16.3%	$6.84-9.9%	$7.59-10.1%
Valuation
Market capitalization	$1.43B+70.7%	$838.92M+5.8%	$793.21M+8.9%	$728.51M-18.0%	$888.69M-12.1%
Price / sales	21.9×+9.6×	12.2×-34.8×	47×+8.7×	38.3×-4.3×	42.6×+29.0×
Price / book	1.8×+0.7×	1.1×+0.1×	1×+0.2×	0.8×-0.1×	0.9×0.0×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Vir Biotechnology, Inc.'s profit margins?: Vir Biotechnology, Inc. (VIR) runs a 96.1% gross margin and a -720.8% operating margin, with a -676.0% net margin.
Where do Vir Biotechnology, Inc.'s ratios come from?: Every ratio is computed from Vir Biotechnology, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.